HEAL Share Price Performance
Recent HEAL News & Updates
No updates
Restart Life Sciences Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.013
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Restart Life Sciences Corp. Competitors
About HEAL
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 0.9%
- 3 Months: 11.0%
- 1 Year: 18.4%
- Year to Date: 10.4%
The market has been flat in the last week, however the Industrials sector is down 3.1%. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
